TrialInvestigative ophthalmology & visual science2013

Safety and efficacy of the multitargeted receptor kinase inhibitor pazopanib in the treatment of corneal neovascularization.

Francisco Amparo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.